Skip to content

Efficacy of Erector Spinae Plane Block Combined with Dexmedetomidine for Analgesia in Thoracolumbar Vertebroplasty: A Two-Center Randomized Controlled Trial

Efficacy of Erector Spinae Plane Block Combined with Dexmedetomidine for Analgesia in Thoracolumbar Vertebroplasty: A Two-Center Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123448
Enrollment
Unknown
Registered
2026-04-27
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracolumbar Vertebral Fracture

Interventions

Group erector spinae plane block:Perform erector spinae plane block
Local anesthesia group:https://chatgpt.com/c/69bb5cd2-f478-832b-9a40-dbde8c71efde#:~:text=Local%20infiltration%20anesthesia%20of%20the%20puncture%20site%20using%201%25%20lid

Sponsors

Lishui peoples hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 65 years; 2.American Society of Anesthesiologists (ASA) physical status classification II–III; 3.No history of major trauma; MRI indicates a fresh spinal fracture (T2 hyperintensity, T1 hypointensity) without spinal canal occupancy or compression. 4.The injured vertebral level ranges from T5 to L5, and elective single-level vertebroplasty is planned;

Exclusion criteria

Exclusion criteria: 1.Pathological vertebral fracture due to spinal tumor; 2.Patients with allergy to local anesthetics; 3.Patients with coagulation disorders; 4.Patients undergoing percutaneous vertebroplasty (PVP) under general anesthesia; 5.Patients with impaired consciousness or inability to communicate effectively; 6.Patients who received analgesic medications preoperatively or have a history of chronic pain; 7.Patients with psychiatric or neurological disorders, impaired consciousness, or inability to communicate effectively; 8.Patients with >=2 injured vertebral segments; 9.Patients who refuse to participate in this study;

Design outcomes

Primary

MeasureTime frame
Incidence of moderate-to-severe intraoperative pain;

Secondary

MeasureTime frame
Maximum intraoperative pain score;Satisfaction with analgesia from the patient, surgeon, and anesthesiologist;Time to first ambulation;Complications and adverse events, including all adverse events such as respiratory depression, severe sinus bradycardia, local anesthetic toxicity, bleeding, nerve injury, infection, and pneumothorax.;Total operating room occupancy time;Total perioperative opioid consumption;Perioperative vital signs (blood pressure, heart rate, SpO?);Incidence of rescue analgesia within 24 hours postoperatively;

Countries

China

Contacts

Public ContactFaxing Wang

Lishui peoples hospital

faxingwanglive@163.com+86 18957092002

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026